• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 12, 2021
Product Development

COVID Quick Takes: subcutaneous Regeneron mAbs prevent symptomatic COVID; plus Pfizer-BionTech, J&J, Akili and Kiniksa

Regeneron reported Phase III data Monday showing subcutaneous REGEN-COV met the primary endpoint of preventing symptomatic COVID-19 in the study’s two populations, and the company plans to
Read More
BioCentury | Jul 30, 2020
Product Development

Finding immunosuppression sweet spot could be next up for COVID-19 after second IL-6 failure

Read More
BioCentury | Jun 19, 2020
Product Development

InflaRx, Kiniksa anti-inflammatory mAbs yield trend toward lower COVID-19 mortality, plus Sinopharm reports antibody readout from vaccine trial

Plus FDA revokes EUA for Chembio serological test, Ortho receives BARDA award for antibody assay
Read More
BioCentury | Nov 6, 2014
Distillery Therapeutics

Indication: Pulmonary disease

Read More
BioCentury | Jun 11, 2009
Distillery Therapeutics

Indication: Neurology

Read More
Items per page:
1 - 5 of 5
Help Center
Username
Request a Demo
Request Training
Ask a Question
Elevio by Dixa